40 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:19pm
be adversely affected;
we rely on third parties to monitor, support, conduct and oversee clinical trials of the product candidates that we
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
.
Risks Related to Our Dependence on Third Parties
We rely on third parties to monitor, support, conduct and oversee clinical trials of the product … business may be materially and adversely affected.
We rely on third parties to monitor, support, conduct and oversee clinical trials of the product
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:15pm
and oversee clinical trials of the product candidates that we are developing and, in some cases, to maintain regulatory files for those product candidates;
our
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:12pm
be adversely affected;
we rely on third parties to monitor, support, conduct and oversee clinical trials of the product candidates that we
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
.
Risks Related to Our Dependence on Third Parties
We rely on third parties to monitor, support, conduct and oversee clinical trials of the product … and our business may be materially and adversely affected.
We rely on third parties to monitor, support, conduct and oversee clinical trials
424B3
h0ilvdfi
13 Jun 24
Prospectus supplement
4:10pm
6-K
EX-99.2
wozads s2
16 May 24
Condensed Interim Consolidated Financial Statements
6:45pm
6-K
EX-99.2
vap6csv0bi9byjp
15 Nov 23
Condensed Interim Consolidated Financial Statements
9:30pm
424B3
2lcqdzq dh
25 Aug 23
Prospectus supplement
6:00am
424B3
3gf0es
25 Aug 23
Prospectus supplement
6:00am
6-K
EX-99.2
73ll2
15 Aug 23
Condensed Interim Consolidated Financial Statements
6:00am
6-K
EX-99.2
0mjxhj
16 May 23
Condensed Interim Consolidated Financial Statements
9:32am
6-K
EX-99.3
z7lsmhk61w6io45
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.2
0fi5ivdks0lbd7w1e938
3 Apr 23
Consolidated Financial Statements
6:05am
424B3
lrbl0y7 5bygdtnr
14 Nov 22
Prospectus supplement
1:51pm
6-K
EX-99.2
twbs3
14 Nov 22
Condensed Interim Consolidated Financial Statements
1:04pm